Timing of thienopyridine loading and outcomes in the TRITON trial: the FDA Prasugrel Action Package outlook
Abstract TR ial to assess I mprovement in T herapeutic O utcomes by optimizing platelet inhibitio N with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38) was a Phase 3,…